Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Sanxin Biotechnology is a national high-tech enterprise specializing in the research, development, production, and sales of plant extracts and related bioactive compounds. The company operates GMP-certified facilities with large-scale extraction capacity (>800 tons/year), exports to over 30 countries including the US and Japan, and has FDA/Kosher certifications. Its products serve multiple industries including food supplements/nutraceuticals, pharmaceuticals (as raw materials), cosmetics, animal health/veterinary medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Sanxin Biotechnology.